Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Automotive Industry Veteran Jacob Tilzer and Accrual Equity Partners Launch Gemba Automotive in Arizona
-
Tannenbaum Helpern Elevates Construction & Design Attorney Hillel E. Sussman to Partner
-
eInfochips Named "IoT Development Service Provider of the Year" at 2026 IoT Breakthrough Awards
-
Scinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL
-
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders
-
Emerita Intersects 2.1m Grading 1.6% Copper, 0.85 g/t Gold, 32.11 g/t Silver and 1.4m Grading 5.8% Copper, 4.89 g/t Gold and 51.0 g/t Silver at El Cura
-
Otis Fourth Quarter and Full Year 2025 Earnings Advisory
-
Monte Rosa Therapeutics Announces Positive Interim Phase 1 Data of MRT-8102 Demonstrating Profound CRP Reductions in Elevated CVD-risk Subjects
-
Levine Leichtman Capital Partners Acquires Signature Resolution
-
Bayer and Cradle enter collaboration to enhance AI-enabled antibody discovery and optimization
-
EyePoint Reports Corporate Update and Anticipated Pivotal Milestones for 2026
-
Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer
-
Missouri American Water Welcomes in the New Year with New Ways to Save
-
Ping Identity Marks Digital Trust Milestone with Zero-Knowledge Biometrics in the Age of AI
-
Criteo Provides Update on Luxembourg Redomiciliation
-
The Blackhawk Group Welcomes Silver Sky Aviation, Expanding Performance Center Network into Alaska with Sixth Location
-
AL-S Pharma to present at the upcoming J. P. Morgan 2026 Annual Healthcare Conference on Thursday, January 15
-
Nanoscope Therapeutics Granted New U.S. Patent Covering Its Proprietary Multi-Characteristic Opsin Platform for Vision Restoration
-
Introducing a Y'all Street Rodeo: Startup Nation Meets the Scale-Up State as Israeli Innovation Heads to Texas
-
Genprex Provides Clinical Update on Diabetes Gene Therapy Program
-
EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan
-
PlusAI to Bolster Board in Connection with Public Listing
-
Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones
-
SAGA Diagnostics® Presents Real-World Pathlight™ MRD Data at ASCO GI 2026
-
QwikOS Debuts World's First Universal Humanoid Operating System and App Store
-
SharkNinja Appoints Jason Wortendyke to Its Board of Directors
-
Lattice Semiconductor to Present at the 28th Annual Needham Growth Conference
-
LEO Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Healthpeak Properties Announces Confidential Submission of Draft Registration Statement by Janus Living, Inc.
-
D-Wave Announces Agreement to Acquire Quantum Circuits Inc., Establishing World’s Leading Quantum Computing Company
-
Main Street Announces New Portfolio Investment
-
Kamada Provides 2026 Annual Guidance of $200 - $205 Million in Revenues and $50 - $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance
-
PlusAI to Participate in Upcoming Investor Conference
-
WARNER BROS. DISCOVERY BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT AMENDED PARAMOUNT TENDER OFFER
-
CCMP Growth Appoints Managing Director Patrick McGrath to Its Investment Committee and Makes Four Additional Firmwide Promotions
-
Wabtec Secures $386 Million Order from New York’s MTA for New Locomotives
-
Automotive innovation through open collaboration: momentum builds around open source software as a key driver of efficiency and success
-
SmartMoving Acquires Remedy Payments to Bring Profit-focused Payments Into the Core Platform
-
Echo Water Launches 40 oz Hydrogen Tumbler for Smarter, All-Day Hydration
-
Aprio Expands in Pacific Northwest, Uniting Two Leading Oregon Firms - Delap LLP and Hoffman, Stewart & Schmidt, P.C.
-
Volastra Therapeutics Expands Clinical Development Program Following Encouraging KIF18A Inhibitor Data and Appoints New Chief Medical Officer to Lead Clinical Strategy
-
BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®
-
Avient To Hold Fourth Quarter 2025 Conference Call
-
ABBYY and Desktop Imaging Fully Automate New Zealand Citizen Services and Enable Frontline Emergency Teams to Focus on Critical Work with Document AI
-
KKR and Oak Hill Capital Commit Nearly $2 Billion to Leading European Data Center Platform Global Technical Realty
-
Stylus Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Hyliion Holdings to Present at the 2026 Needham Growth Conference on January 16, 2026
-
BOARDWALK REIT PROVIDES OPERATIONAL AND CAPITAL ALLOCATION UPDATE AND ANNOUNCES TIMING OF FOURTH QUARTER RESULTS
-
Roblox Requires Users Worldwide to Age-Check to Access Chat
-
Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism
